SGLT2 inhibitors reduce recurrent flares and hospitalizations in patients with gout
1. In this population cohort study, patients with gout who used sodium-glucose cotransporter-2 inhibitors (SGLT2is) experienced fewer recurrent flares than ...
Tag: Dipeptidyl Peptidase-4 Inhibitors
GLP-1 receptor agonists lower adverse cardiac event risk in veterans with type 2 diabetes
1. In this retrospective cohort study, glucagon-like peptide-1 receptor agonists (GLP1RA) were associated with a lower risk of major adverse ...